Investor Update
Basel, 29 October 2007
Reminder:
Roche’s
Investor and Analyst Briefing on our Hepatitis Franchise at AASLD
List of Roche abstracts
at AASLD available on website
Monday, 5th November,
2007
During the 58th AASLD meeting in Boston, Roche and its collaborators
will present a large number of abstracts on Pegasys and the company’s promising pipeline of hepatitis
C compounds in clinical development. Roche has prepared a short planner providing an overview of oral
and poster abstracts relevant to Roche and its partners, which can be downloaded from
the website.
Roche’s Investor and Analyst Briefing
on our Hepatitis Franchise at AASLD
A summary of the key data presented at AASLD
by Roche and its collaborators, an up-date of Roche’s Hepatitis portfolio and an overview of the company’s
clinical trial program will be provided at the Analyst Briefing at AASLD.
Following
the briefing Roche will host a dinner and informal discussion on the Hepatitis franchise and overall
business.
| Event Date: | Monday, 5th November, 2007 |
| Speakers: | Dr. Paul Pockros, Scripps Clinic, San Diego, California |
| Claire Steers, Roche Lifecycle Leader Pegasys, Basel | |
| Dr. Frank Duff, Roche Head Clincial Development Virology, Palo Alto | |
| Briefing commences: | 18:30 - 20:00 EDT (Boston) |
| 00:30 - 02:00 CET (Zurich) | |
| 23:30 - 01:00 GMT (London) | |
| Apéro and Dinner: | 20:00 EDT |
| Location: | Hotel Westin Copley Place Boston |
| Meeting Room “Great Republic, 7th floor” | |
| 10 Huntington Avenue, Boston |
Concurrent
conference call: Dial in to the conference
10-15 min prior to the scheduled start using the following numbers:
- +41 (0) 91 610 56 00 (Europe and ROW)
- +1 (1) 866 291 41 66 (USA Toll Free)
- +44 (0) 207 107 06 11 (UK)
Presentation
slides will be posted on the
Roche IR website ir.roche.com.
Alternatively a live
audio webcast can be accessed
via ir.roche.com
A replay of the conference
call will be available
one hour after the conference call, for 48 hours. Access by dialing:
- +41 91 612 43 30 (Europe and ROW) or
- +44 207 108 62 33 (UK)
- +1 (1) 866 416 25 58 (USA)
- Enter the ID 338 followed by the # sign.
A replay of the webcast will be available on demand at ir.roche.com.